Navigation Links
Arthritis Associates of South Florida Acquires Access to Patient Health History Faster with Digital Pen Technology from Anoto and NextGen Healthcare
Date:7/10/2012

WESTBOROUGH, Mass., July 10, 2012 /PRNewswire/ -- Anoto Group, the worldwide leader in Digital Pen and Paper technology, and NextGen Healthcare Information Systems, LLC announced that Arthritis Associates of South Florida has experienced significant benefits since implementing digital pen and paper technology - particularly when importing medical family and social history into their EHR solution.

(Logo: http://photos.prnewswire.com/prnh/20120330/NE79515LOGO )

Arthritis Associates of South Florida specializes in adult and pediatric rheumatology. They treat all types of arthritis and autoimmune disorders through nonsurgical means. Previously, notes from patient visits would be dictated and transcribed and would take about three days to process. Now, by just having the patient fill out a form with a digital pen, the practice can immediately bring relevant data directly into their EHR system. This has resulted in improved efficiency – especially for new patients.

"The information and health history we capture is invaluable in our being able to determine a diagnosis," said Steven I. Goodman, M.D. "Now patients can just fill out forms with the digital pen and we can quickly capture details, such as where they are having pain, how severe it is, what makes it better and what makes it worse. Now, when I walk into the room, I have access to everything I need – it's all right there."

The system works exactly like traditional pen and paper. Each medical assistant is assigned two pens. They provide the patient with the form and the digital pen and then later check to make sure that the data is downloaded correctly. The handwritten information is recorded onto a chip in the digital pen. When the form is completed, the data in the pen is transferred via a computer docking station. The handwritten information is then converted into electronic data for immediate use.  The solution also helps to achieve meaningful use standards since the forms contain details such as smoking history, race and demographic information.

"Digital pen and paper technology is enabling healthcare organizations like Arthritis Associates of South Florida to increase efficiencies while also helping them to move toward achieving Meaningful Use," said Pietro Parravicini, senior vice president area manager Americas for Anoto. "Digital pens can quickly capture important information and are very easy to use for staff and patients alike, resulting in immediate benefits."

In addition to their current use of the technology, Arthritis Associates of South Florida is looking to expand the combined solution from Anoto and NextGen Healthcare within its practice to collect data for disease activity levels for rheumatoid arthritis. They are currently in the process of developing a template that patients can use to fill out with questions reflecting the active level of their condition. The practice believes this will help doctors more quickly and easily prescribe what is needed to improve patient comfort and outcomes.

About Anoto Group Anoto Group is the company behind and world leading in the unique technology for digital pen and paper, which enables fast and reliable transmission of handwritten text into a digital format. Anoto operates through a global partner network that focuses on user-friendly solutions for efficient capture, transmission and storage of data within different business segments, e.g. healthcare, bank and finance, transport and logistics and education. The Anoto Group has around 100 employees and is headquartered in Lund (Sweden). The company also has offices in Guildford and Wetherby (UK), Boston (US) and Tokyo (Japan). The Anoto share is traded on the Small Cap list of NASDAQ OMX Stockholm under the ticker ANOT. For more information: www.anoto.com.

About NextGenHealthcare NextGen Healthcare Information Systems, LLC, a wholly owned subsidiary of Quality Systems, Inc., provides integrated clinical, financial and connectivity solutions for ambulatory, inpatient and dental provider organizations. For more information, please visit www.nextgen.com and www.qsii.com. Follow NextGen Healthcare on Twitter at www.twitter.com/nextgen or Facebook at http://www.facebook.com/NextGenHealthcare

For more information contact:

Karen Pantinas Davies Murphy Group kpantinas@daviesmurphy.com  781-418-2413 

 


'/>"/>
SOURCE Anoto Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Flexions Lead Osteoarthritis Drug Candidate Demonstrates Significant, Prolonged Improvement in Pain and Function in Phase 2 Trial
2. Lilly and Incytes Oral JAK1 and JAK2 Inhibitor, Baricitinib, Showed Positive Results in Phase IIb Study in Patients with Active Rheumatoid Arthritis
3. Innovations for Osteoarthritis, Sports Injuries and Orthopedic Practices
4. Aethlon Medical to Present at Todays Security Research Associates 8th Annual Growth Conference
5. Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences
6. Sensus Healthcare and Texas Dermatology Associates at Baylor University Medical Center Announce the Formation of the SRT University™ Comprehensive Education Series for Practitioners, Healthcare Professionals, and Patients
7. Schulman Associates IRB offers oncology-focused review board
8. Kaiser Permanente Ranks Highest in 2012 J.D. Power and Associates Employer Satisfaction Study for Second Year in a Row
9. Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings
10. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
11. Synteract Sponsoring and Presenting at Outsourcing in Clinical Trials Southeast Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... , Feb. 27, 2017  A ... P. Vallely , MBBS, PhD, FRACS, of  Sydney ... University of Sydney will be published in ... of the American College of Cardiology ... beating heart bypass surgery technique (anOPCABG) reduced ...
(Date:2/27/2017)... Biophysics Corporation, a global medical device manufacturer based in ... growth in 2016 when compared to the previous year based ... fueled by its AffloVest® sales in the United ... global sales of surgical product lines. Said H. ... 25 th year in delivering high-quality, innovative medical devices ...
(Date:2/27/2017)... ROCKVILLE, Md. , Feb. 27, 2017 /PRNewswire/ ... "RegeneRx"), a clinical-stage drug development company focused on ... its licensee for RGN-137, GtreeBNT Co., Ltd., received ... its Phase 3 clinical trial design for RGN-137 ... dermal wound healing gel that incorporates Thymosin beta ...
Breaking Medicine Technology:
(Date:2/27/2017)... ... February 27, 2017 , ... ... overview on laser diffraction analysis as a tool to characterize particle size distributions ... potential to obtain improved results and novel scientific findings. It describes methods of ...
(Date:2/27/2017)... , ... February 27, 2017 , ... POUGHKEEPSIE, N. Y. ... has disclosed that despite scientific studies, the Center for Disease Control ( CDC ) ... disease . Kenneth B. Liegner, M.D. has compiled into a single volume a ...
(Date:2/27/2017)... BC (PRWEB) , ... February 27, 2017 , ... ... drug rehabilitation and alcohol treatment programs in British Columbia, Canada, at https://www.sunshinecoasthealthcentre.ca/ ... to its team. The new hire, Mackenzie Alsager, showcases the Centre's commitment to ...
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... ... San Francisco and environs, is proud to announce an upgrade to the company's ... the upgraded Yelp page on topics as diverse as Platelet Rich Plasma (PRP) ...
(Date:2/26/2017)... ... February 25, 2017 , ... The February 13, 2017, assassination of Kim ... over nerve agents and the deadly use of chemical weapons. Many questions exist about ... even small doses can be lethal. , Jay Jagannathan, M.D., of Michigan-based Jagannathan Neurosurgical ...
Breaking Medicine News(10 mins):